GM PHARMA in Europe!
The international pharmaceutical company GM PHARMA successfully participated in CPHI Frankfurt 2025, one of the world’s largest and most influential international pharmaceutical exhibitions.
GM PHARMA was the only company from Georgia represented at the forum with its own exhibition stand.
For more than three decades, CPHI has served as the world’s leading platform for innovation, data and technology exchange within the pharmaceutical industry.
The exhibition brought together 2,400 exhibitors, 62,000 visitors and over 250 international expert speakers from nearly 160 countries.
During the event, GM PHARMA’s team held numerous successful meetings with current and potential partners, focusing on the development of in-licensing agreements (EU CTD dossiers registered across the EU), formulation and analytical development, technology transfer and contract manufacturing opportunities.
At the core of GM PHARMA’s values is an unwavering commitment to patient health - improving lives, extending longevity and delivering medicines of the highest quality.